New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
15:11 EDTZMHZimmer valuation not reflecting Biomet deal potential, says Cantor
Cantor says Zimmer remains its preferred name in orthopedics despite its "disappointing" Q2 report, as the firm believes the stock's valuation doesn't properly reflects the potential from its tie-up with Biomet. Cantor thinks Zimmer management's synergy targets are possibly conservative and raised its price target on the stock to $117 from $113.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:12 EDTZMHAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
07:02 EDTZMHZimmer announces clearance by Japan FTC of pending Biomet merger
Subscribe for More Information
March 18, 2015
12:06 EDTZMHEU set to conditionally approve Zimmer, Biomet deal, Reuters reports
The European Union is set to give conditional approval to Zimmer's proposed acquisition of Biomet, Reuters reports, citing two people with knowledge of the matter. Reference Link
10:52 EDTZMHZimmer deal for Biomet unlikely delayed by DPA, says Piper Jaffray
Subscribe for More Information
10:46 EDTZMHZimmer says DOJ extended Biomet DPA for another year
Subscribe for More Information
March 16, 2015
08:05 EDTZMHZimmer announces first clinical use of Vivacit-E liner
Zimmer announced its first reverse shoulder replacement in the United States using Vivacit-E Liner for the Trabecular Metal Reverse Shoulder System.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use